Thus, the association of TRAIL expression in TEpCs of patients with negative lymph nodes might reflect the apoptotic effects of TRAIL that delay tumor progression as well as the extravasation of tumor cells to regional lymph nodes [23]. Here, TNFSF10 is linked to neoplasm.